{"zip": "201210", "sector": "Healthcare", "fullTimeEmployees": 628, "longBusinessSummary": "Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd., together with its subsidiaries, researches, develops, manufactures, and sells bio-pharmaceutical products. It offers genetic engineering platform drugs, including CD30-MMAE, which is in clinical trial Phase I for tumors; Trop 2 antibody-conjugated drug that is in pre-clinical studies for triple negative breast cancer, bladder and gastric cancer, and other tumors; and HER2 antibody-drug conjugate, which is in pre-clinical study for tumors. The company also provides photodynamic technical platform drugs, such as hemoporfin for port wine stain, which is in Phase IV clinical trial; aminolevulinic acid, which is in Phase II clinical trials for cervical diseases infected by HPV; and aminolevulinic acid that is in Phase I clinical trials for acne, as well as completed pre-clinical study for brain gliomas. In addition, it offers nano technical platform drugs comprising Nanoparticle Albumin-bound Paclitaxel that is in pre-clinical studies for tumors, as well as developing Doxorubicin liposome for tumors. Further, the company offers oral solid preparation technology, which includes obeticholic acid for Hepatobiliary disease; and JAK1 inhibitor that is in Phase I clinical trial for rheumatoid arthritis. Additionally, it researches and develops pharmaceutical and medical devices; medical diagnostic products; provides related services; and sells daily necessities, and clinical laboratory analysis instruments and software. It also engages in the technology development, transfer, consulting, and promotion activities; and production of freeze-dried powder injections and APIs, as well as invests in overseas medical projects. The company was founded in 1996 and is based in Shanghai, the People's Republic of China.", "city": "Shanghai", "phone": "86 21 5895 3355", "country": "China", "companyOfficers": [], "website": "http://www.fd-zj.com", "maxAge": 1, "address1": "Zhangjiang Hi-Tech Park", "fax": "86 21 5855 3990", "industry": "Drug Manufacturers\u2014Specialty & Generic", "address2": "No. 308 Cailun Road Pudong", "ebitdaMargins": 0.19511999, "profitMargins": 0.19159001, "grossMargins": 0.92735, "operatingCashflow": 240775584, "revenueGrowth": 0.148, "operatingMargins": 0.15883, "ebitda": 202083248, "targetLowPrice": null, "recommendationKey": "none", "grossProfits": 769689854, "freeCashflow": 76538496, "targetMedianPrice": null, "currentPrice": 3.87, "earningsGrowth": -0.209, "currentRatio": 4.229, "returnOnAssets": 0.04146, "numberOfAnalystOpinions": null, "targetMeanPrice": null, "debtToEquity": 1.598, "returnOnEquity": 0.09894, "targetHighPrice": null, "totalCash": 1129497216, "totalDebt": 33003180, "totalRevenue": 1035703488, "totalCashPerShare": 0.983, "financialCurrency": "CNY", "revenuePerShare": 0.949, "quickRatio": 4.103, "recommendationMean": null, "exchange": "HKG", "shortName": "FUDANZHANGJIANG", "longName": "Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.", "exchangeTimezoneName": "Asia/Hong_Kong", "exchangeTimezoneShortName": "HKT", "isEsgPopulated": false, "gmtOffSetMilliseconds": "28800000", "quoteType": "EQUITY", "symbol": "1349.HK", "messageBoardId": "finmb_8288321", "market": "hk_market", "annualHoldingsTurnover": null, "enterpriseToRevenue": 3.231, "beta3Year": null, "enterpriseToEbitda": 16.561, "52WeekChange": 0.018421054, "morningStarRiskRating": null, "forwardEps": 0.28, "revenueQuarterlyGrowth": null, "sharesOutstanding": 331649984, "fundInceptionDate": null, "annualReportExpenseRatio": null, "totalAssets": null, "bookValue": 1.8, "sharesShort": null, "sharesPercentSharesOut": null, "fundFamily": null, "lastFiscalYearEnd": 1609372800, "heldPercentInstitutions": 0.14981, "netIncomeToCommon": 198429152, "trailingEps": 0.167021, "lastDividendValue": 0.05, "SandP52WeekChange": 0.31910443, "priceToBook": 2.15, "heldPercentInsiders": 0.20753999, "nextFiscalYearEnd": 1672444800, "yield": null, "mostRecentQuarter": 1632960000, "shortRatio": null, "sharesShortPreviousMonthDate": null, "floatShares": 424278582, "beta": 0.583005, "enterpriseValue": 3346754816, "priceHint": 3, "threeYearAverageReturn": null, "lastSplitDate": null, "lastSplitFactor": null, "legalType": null, "lastDividendDate": 1622505600, "morningStarOverallRating": null, "earningsQuarterlyGrowth": -0.047, "priceToSalesTrailing12Months": 3.8660634, "dateShortInterest": null, "pegRatio": null, "ytdReturn": null, "forwardPE": 13.821428, "lastCapGain": null, "shortPercentOfFloat": null, "sharesShortPriorMonth": null, "impliedSharesOutstanding": 1034649984, "category": null, "fiveYearAverageReturn": null, "previousClose": 3.87, "regularMarketOpen": 3.8, "twoHundredDayAverage": 4.6113667, "trailingAnnualDividendYield": 0.012919897, "payoutRatio": 0.2546, "volume24Hr": null, "regularMarketDayHigh": 3.87, "navPrice": null, "averageDailyVolume10Day": 813875, "regularMarketPreviousClose": 3.87, "fiftyDayAverage": 3.9358823, "trailingAnnualDividendRate": 0.05, "open": 3.8, "toCurrency": null, "averageVolume10days": 813875, "expireDate": null, "algorithm": null, "dividendRate": 0.06, "exDividendDate": 1622505600, "circulatingSupply": null, "startDate": null, "regularMarketDayLow": 3.8, "currency": "HKD", "trailingPE": 23.170738, "regularMarketVolume": 550000, "lastMarket": null, "maxSupply": null, "openInterest": null, "marketCap": 4004095232, "volumeAllCurrencies": null, "strikePrice": null, "averageVolume": 1228873, "dayLow": 3.8, "ask": 3.88, "askSize": 0, "volume": 550000, "fiftyTwoWeekHigh": 5.8, "fromCurrency": null, "fiveYearAvgDividendYield": null, "fiftyTwoWeekLow": 3.71, "bid": 3.84, "tradeable": false, "dividendYield": 0.0155, "bidSize": 0, "dayHigh": 3.87, "regularMarketPrice": 3.87, "preMarketPrice": null, "logo_url": "https://logo.clearbit.com/fd-zj.com"}